Option Care Health acquired Revitalize Specialty Infusion for $12.5 million in May 2023. This acquisition expanded Option Care Health's capabilities in providing in-home intravenous treatments.
Nathanael Farrelly, the founder of Revitalize Specialty Infusion, remained with Option Care Health for a year following the acquisition to support the transition. This integration period aimed to ensure continuity and leverage the acquired expertise.
The acquisition of Revitalize Specialty Infusion demonstrates Option Care Health's strategy to grow its home and alternate site infusion services. This move enhances its network and service offerings in the evolving healthcare landscape.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.